Experiment: 2MRI

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.5mM [U-100% 13C, U-100% 15N] Protein-1, 20mM TRIS-2, 50mM sodium chloride-3	90% H2O/10% D2O	0.07	7.5	ambient	298
2	2D 1H-13C HSQC	0.5mM [U-100% 13C, U-100% 15N] Protein-1, 20mM TRIS-2, 50mM sodium chloride-3	90% H2O/10% D2O	0.07	7.5	ambient	298
3	3D CBCA(CO)NH	0.5mM [U-100% 13C, U-100% 15N] Protein-1, 20mM TRIS-2, 50mM sodium chloride-3	90% H2O/10% D2O	0.07	7.5	ambient	298
4	3D HNCO	0.5mM [U-100% 13C, U-100% 15N] Protein-1, 20mM TRIS-2, 50mM sodium chloride-3	90% H2O/10% D2O	0.07	7.5	ambient	298
5	3D HNCA	0.5mM [U-100% 13C, U-100% 15N] Protein-1, 20mM TRIS-2, 50mM sodium chloride-3	90% H2O/10% D2O	0.07	7.5	ambient	298
6	3D HNCACB	0.5mM [U-100% 13C, U-100% 15N] Protein-1, 20mM TRIS-2, 50mM sodium chloride-3	90% H2O/10% D2O	0.07	7.5	ambient	298
7	3D HBHA(CO)NH	0.5mM [U-100% 13C, U-100% 15N] Protein-1, 20mM TRIS-2, 50mM sodium chloride-3	90% H2O/10% D2O	0.07	7.5	ambient	298
8	3D 1H-15N NOESY	0.5mM [U-100% 13C, U-100% 15N] Protein-1, 20mM TRIS-2, 50mM sodium chloride-3	90% H2O/10% D2O	0.07	7.5	ambient	298
9	3D HCCH-COSY	0.5mM [U-100% 13C, U-100% 15N] Protein-1, 20mM TRIS-2, 50mM sodium chloride-3	90% H2O/10% D2O	0.07	7.5	ambient	298
10	3D CCH-TOCSY	0.5mM [U-100% 13C, U-100% 15N] Protein-1, 20mM TRIS-2, 50mM sodium chloride-3	90% H2O/10% D2O	0.07	7.5	ambient	298
11	3D 1H-13C NOESY	0.5mM [U-100% 13C, U-100% 15N] Protein-1, 20mM TRIS-2, 50mM sodium chloride-3	90% H2O/10% D2O	0.07	7.5	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	800
2	Bruker	AVANCE	500

NMR Refinement
Method	Details	Software
simulated annealing		Amber

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	Amber		Case, Darden, Cheatham, III, Simmerling, Wang, Duke, Luo, and Kollman

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.